By SPC News Staff
Practitioners and new mothers suffering from relapsing multiple sclerosis (RMS) often wonder whether the mothers can continue disease-modifying treatment during pregnancy and breastfeeding without putting their child at risk.
A study of the branded version of glatiramer acetate (Copaxone, Teva) may help practitioners and mothers decide whether glatiramer acetate can be used while breastfeeding. The comparative study between children whose mothers had taken the drug while